Vitamin C and Atrial Fibrillation After Cardiac Surgery

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Atrial Fibrillation

In brief

The purpose of this study is to determine if vitamin C decreases the chance of developing atrial fibrillation, a type of arrhythmia or irregular heartbeat, following cardiac surgery. This irregular heartbeat is a common occurrence following cardiac surgery, and occurs in about one third of patients. It poses extra risks to people who develop it. Our hypothesis is that Vitamin C will decrease the incidence of postoperative atrial fibrillation.

Key facts

Study ID

NCT01580683

Run by

Regional Hospital of Scranton

People needed

0

Starts

2012-07-01

Expected to finish

2015-08-01

Last updated by the study team

2015-05-13

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 50 years of age or older
• Undergoing elective or urgent coronary artery bypass graft surgery, valve surgery, or a combination of the two

You may not qualify if…

• Prior cardiac surgery
• History of atrial fibrillation
• Permanent or temporary pace maker
• Currently taking digoxin or Vaughan Williams Class I or III antiarrhythmic medications
• Known hyperoxaluria
• History of renal calculi
• History of allergic or hypersensitivity reaction to ascorbic acid products
• Currently taking 1 g or more of ascorbic acid supplementation daily

Where it is running

• Regional Hospital of Scranton — Scranton, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.